Skip to main content
. Author manuscript; available in PMC: 2023 Oct 20.
Published in final edited form as: Antiviral Res. 2019 Feb 12;164:70–80. doi: 10.1016/j.antiviral.2019.02.005

Table 4:

Inhibition of cccDNA by selected compounds

Compound HepBHAe82_ AlphaLISA_eAg HepBHAe82_ Cytotoxicity
EC50 (μM) CC50 (μM)
HID
A19 1.3 ± 0.39 >25
HPD
A13 1.5 ± 0.94 >25
A15 0.76 ± 0.71 >25
A22 0.56 ± 0.34 >25
A23 0.56 ± 0.2 >25
A24 0.43 ± 0.11 >25
A25 0.65 ± 0.51 >25